新型氘代谢成像揭示1型糖尿病与健康对照餐后肝糖代谢差异
该病例对照研究纳入10例成人1型糖尿病和10例健康对照,采用氘代谢成像与13C磁共振波谱结合全身示踪剂稀释法,评估餐后肝脏葡萄糖代谢。结果显示1型糖尿病者餐后肝内D-葡萄糖升高更明显、糖原未显著增加,内源性葡萄糖生成抑制显著减弱,且存在两种代谢亚型。
要点
- 1型糖尿病者餐后肝D-葡萄糖峰值显著高于对照(4.7 vs 3.0 mmol/l)。
- 1型糖尿病者餐后150分钟肝糖原无显著升高,对照则明显增加。
- 1型糖尿病者内源性葡萄糖生成抑制显著减弱(p=0.001)。
核心结论
- 整合氘代谢成像与13C磁共振波谱及全身稳定同位素建模,发现成人1型糖尿病较健康对照存在显著 altered 肝脏葡萄糖代谢。
- 1型糖尿病队列内部存在明显表型异质性,可分为两个代谢亚组。
研究设计与样本
- 横断面病例对照研究,纳入10例成人1型糖尿病和10例健康对照,年龄、BMI和性别分布相似。
- 隔夜空腹后摄入60 g [6,6'-2H2]-葡萄糖,1型糖尿病者按碳水-胰岛素比皮下注射胰岛素。
- 摄入前至摄入后150分钟行7 T氘代谢成像与13C磁共振波谱,并采集血样测血糖、胰岛素和胰高血糖素。
- 采用单示踪剂口服最小模型量化餐后葡萄糖-胰岛素动力学,考虑非稳态胰岛素暴露。
主要发现
- 基线时1型糖尿病者血浆葡萄糖显著高于对照(10.7±2.3 vs 5.2±0.4 mmol/l,p<0.001),餐前糖原水平无显著差异。
- 给予D-葡萄糖后,1型糖尿病者肝D-葡萄糖升高更明显(峰值4.7±2.0 vs 3.0±0.8 mmol/l,p=0.02)。
- 餐后150分钟1型糖尿病者肝糖原未显著升高,对照可见明显增加(iAUC0-180=2.4 mol/l × min)。
- 两组全身胰岛素暴露相似且餐后胰高血糖素无显著差异,但1型糖尿病者内源性葡萄糖生成抑制显著减弱(p=0.001),胰岛素依赖的葡萄糖处置相似。
- 层次聚类识别两个1型糖尿病亚组:亚组1肝和全身D-葡萄糖上升更陡,亚组2轨迹不同且净糖原耗竭(iAUC0-180=-3.0 vs 2.5 mol/l × min,p=0.04),两亚组无明显临床差异。
临床怎么用
- 氘代谢成像联合13C磁共振波谱可无创评估1型糖尿病餐后肝脏葡萄糖代谢改变。
- 1型糖尿病者内源性葡萄糖生成抑制减弱,提示皮下胰岛素替代不能完全模拟门脉胰岛素生理梯度。
- 1型糖尿病内部存在代谢表型异质性,未来或可指导精准医学分型管理。
局限性
- 样本量小(每组10例),结果需更大队列验证。
- 为横断面病例对照设计,不能推断因果关系。
- 1型糖尿病者基线血糖显著高于对照,可能影响代谢指标比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Subcutaneous insulin delivery in individuals with insulin-deficient type 1 diabetes bypasses the portal circulation, disrupting the physiological porto-systemic insulin gradient and affecting postprandial hepatic glucose regulation. However, direct, non-invasive measurement of these liver-specific dynamics and their deviation from normal physiology in individuals with type 1 diabetes is challenging. To address this, we integrated metabolic imaging with whole-body tracer dilution to map postprandial glucose metabolism in both the liver and systemically in adults with type 1 diabetes and healthy control individuals. METHODS: In this cross-sectional study, ten adults with type 1 diabetes and ten healthy control individuals with similar age, BMI and gender distributions were enrolled. After an overnight fast, participants ingested 60 g [6,6'-2H2]-glucose (D-Glc); subcutaneous insulin was administered to type 1 diabetes participants according to their carbohydrate-to-insulin ratio. Interleaved deuterium metabolic imaging (DMI) and 13C-magnetic resonance spectroscopy (13C-MRS) at 7 T were performed from pre-ingestion to 150 min post-ingestion to quantify hepatic D-Glc and glycogen concentrations. Blood samples were collected to measure plasma glucose, insulin and glucagon. Postprandial glucose-insulin dynamics were quantified using the single tracer oral minimal model, accounting for non-steady-state insulin exposure. RESULTS: At baseline, individuals with type 1 diabetes had significantly higher plasma glucose concentrations than control individuals (10.7±2.3 and 5.2±0.4 mmol/l, respectively; p<0.001), while preprandial glycogen levels did not differ significantly. Following D-Glc administration, hepatic D-Glc increased more markedly in the individuals with type 1 diabetes compared with the control group (peak values 4.7±2.0 and 3.0±0.8 mmol/l, respectively; p=0.02). In the postprandial period, glycogen levels did not significantly rise at 150 min in type 1 diabetes, whereas a clear increase was observed in control individuals (iAUC0-180=2.4 mol/l × min). Despite similar systemic insulin exposure and no significant differences in postprandial glucagon concentrations between groups, individuals with type 1 diabetes demonstrated significantly reduced suppression of endogenous glucose production (p=0.001) but similar insulin-dependent glucose disposal. Hierarchical clustering identified two distinct type 1 diabetes subgroups: Subgroup 1 exhibited a steeper increase in both hepatic and systemic D-Glc profiles, while subgroup 2 showed a divergent D-Glc trajectory and net glycogen depletion relative to accumulation in subgroup 1 (iAUC0-180=-3.0 vs 2.5 mol/l × min, p=0.04), despite no overt clinical differences between subgroups. CONCLUSIONS/INTERPRETATION: By integrating DMI/13C-MRS liver imaging with systemic stable-isotope modelling, this comparative study demonstrates significantly altered hepatic glucose metabolism in adults with well-managed type 1 diabetes vs control individuals, together with substantial phenotypic heterogeneity within the type 1 diabetes cohort. These findings highlight the potential of non-invasive metabolic phenotyping to resolve metabolic alterations and inter-individual variation in type 1 diabetes, which are essential steps towards the provision of precision medicine.
引用
- Brunasso A, Lange NF, Poli S, et al. Novel deuterium metabolic imaging technique reveals distinct patterns of postprandial hepatic glucose homeostasis in individuals with type 1 diabetes and healthy control individuals: a case-control study. Diabetologia. 2026. PMID: 41686194. doi:10.1007/s00125-026-06677-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。